A trial of donanemab, an experimental drug, found it modestly slowed the worsening of memory and thinking and worked better in patients at earlier stages and those under 75.
Tag: Alzheimer’s Disease
-
What to Know About Leqembi, the Alzheimer’s Drug Approved by the FDA
Medicare will cover much of the cost for patients in the early stages of the disease, but Leqembi has safety risks and can only modestly slow cognitive decline.
-
FDA Makes Alzheimer’s Drug Leqembi Widely Accessible
The F.D.A. gave full approval to the drug, but added a black-box warning about safety risks. Medicare said it would cover most of the high cost.
-
As Cases Soar, ‘Dementia Villages’ Look Like the Future of Home Care
A new generation of treatment facilities is aiming to integrate dementia patients with the communities around them, blurring lines between home and hospital.
-
Former First Lady Rosalynn Carter Has Dementia
The announcement by the Carter Center came just over three months after it said that Jimmy Carter, 98, had entered hospice care at the couple’s home in Plains, Ga.